A Covid-19 vaccine could be broadly rolled out in the United States by the middle of 2021 or a little later, the head of the federal government’s disease control agency said.
Qiagen readies launch of rapid COVID-19 antigen test (Reuters) – German diagnostic test maker Qiagen on Tuesday said it planned to launch a COVID-19 antigen test that can provide results […]
Point-of-care testing is a critical tool in the battle against Covid-19, and researchers in Indiana are working around the clock to deliver rapid tests with high specificity.
The National Institutes of Health is investing $248.7 million in seven diagnostic companies with new testing technologies to increase their testing capacities and make millions of rapid Covid-19 tests per week available by fall.
